Search

Timothy M. Speer

Supervisory Patent Examiner (ID: 6243, Phone: (571)272-8385 , Office: P/3992 )

Most Active Art Unit
1775
Art Unit(s)
1784, 1772, 3992, 1774, 1773, 3991, 1508, 1775, 1794, 1315
Total Applications
1113
Issued Applications
820
Pending Applications
109
Abandoned Applications
193

Applications

Application numberTitle of the applicationFiling DateStatus
19/319333 ORGANOSILOXANE COMPOUND AND SURFACE TREATMENT AGENT Sep 3, 2025 Pending
19/316764 METHODS FOR TREATING NEUROLOGICAL CONDITIONS AND EXPOSURE TO NERVE AGENTS Sep 1, 2025 Pending
19/312085 RECOMBINANT ADENOVIRUSES AND USE THEREOF Aug 26, 2025 Pending
19/299178 BATTERY MODULE, BATTERY PACK INCLUDING BATTERY MODULE, AND VEHICLE INCLUDING BATTERY PACK Aug 12, 2025 Pending
19/299178 BATTERY MODULE, BATTERY PACK INCLUDING BATTERY MODULE, AND VEHICLE INCLUDING BATTERY PACK Aug 12, 2025 Pending
19/295195 BENZOXAZEPIN OXAZOLIDINONE COMPOUNDS AND METHODS OF USE Aug 7, 2025 Pending
19/295195 BENZOXAZEPIN OXAZOLIDINONE COMPOUNDS AND METHODS OF USE Aug 7, 2025 Pending
19/295195 BENZOXAZEPIN OXAZOLIDINONE COMPOUNDS AND METHODS OF USE Aug 7, 2025 Pending
19/293815 NEURAL REGENERATING CELLS WITH ALTERATIONS IN DNA METHYLATION Aug 6, 2025 Pending
19/282828 VITAMIN D COMPOSITIONS AND METHOD OF ADMINISTRATION TO A HUMAN BEING Jul 31, 2025 Pending
19/280037 IMIDAZOLOTHIAZOLE COMPOUNDS FOR THE TREATMENT OF DISEASE Jul 23, 2025 Pending
19/269025 DISPOSABLE TANK ELECTRONIC CIGARETTE, METHOD OF MANUFACTURE AND METHOD OF USE Jul 13, 2025 Pending
19/259297 Pyrazolopyrimidine Compounds As Kinase Inhibitors Jul 2, 2025 Pending
19/237891 COVALENT INHIBITORS OF KRAS G12C Jun 12, 2025 Pending
19/237891 COVALENT INHIBITORS OF KRAS G12C Jun 12, 2025 Pending
19/230943 THERAPY FOR TREATING MALIGNANCIES Jun 5, 2025 Pending
19/230943 THERAPY FOR TREATING MALIGNANCIES Jun 5, 2025 Pending
19/183447 Battery Configurations Having Balanced Current Collectors Apr 17, 2025 Pending
19/183447 Battery Configurations Having Balanced Current Collectors Apr 17, 2025 Pending
19/180576 Antibody Having Improved Stability And Specifically Binding To HER2 Apr 15, 2025 Pending
Menu